Tratamiento de la enfermedad de chagas con nifurtimox durante los primeros meses de vida

Moya, P. R; Blanco, Sonia; Lapasset, María; Sanmartino, Concepción; Basso, Beatriz; Moreti, E; Cura, Delia; Pao Lasse, Rose D.
Medicina (B.Aires) ; 45(5): 553-8, 1985. tab
Artículo en Español | LILACS | ID: lil-26625

Documentos relacionados

  1. Amplicon Sequencing Reveals Complex Infection in Infants Congenitally Infected With Trypanosoma Cruzi and Informs the Dynamics of Parasite Transmission.
  2. Chagas Disease.
  3. Epidemiology of Chagas disease in pregnant women and congenital transmission of Trypanosoma cruzi in the Americas: systematic review and meta-analysis.
  4. B-Cell Responses in Chronic Chagas Disease: Waning of Trypanosoma cruzi-Specific Antibody-Secreting Cells Following Successful Etiological Treatment.
  5. Circulating Cytokine and Chemokine Profiles of Trypanosoma cruzi-Infected Women During Pregnancy and Its Association With Congenital Transmission.
  6. Serum Cytokines as Biomarkers of Early Trypanosoma cruzi infection by Congenital Exposure.
  7. Chagas disease in immunocompromised patients.
  8. Effect of B-NIPOx in Experimental <i>Trypanosoma cruzi</i> Infection in Mice.
  9. Treatment of Infected Women of Childbearing Age Prevents Congenital Trypanosoma cruzi Infection by Eliminating the Parasitemia Detected by PCR.
  10. Chagas Disease.